Berry Street Capital Management’s Edwards Lifesciences EW Stock Holding History

Berry Street Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$3.46M	Buy	+50,000	New	+$4.02M	1.02%	23

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Berry Street Capital Management's EW Position: Q3 2023 in Review

Berry Street Capital Management opened a new position in Edwards Lifesciences (EW) in Q3 2023: 50,000 shares worth $3.46M. The stake represents 1.02% of the portfolio and ranks #23 among its holdings.

1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.

Berry Street Capital Management held 50,000 shares of Edwards Lifesciences worth $3.46M as of Q3 2023.
Edwards Lifesciences was a new Berry Street Capital Management position in Q3 2023.
Edwards Lifesciences made up 1.02% of Berry Street Capital Management's portfolio in Q3 2023, its #23 holding.
1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Berry Street Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.